Incorporate gene signature profiling into routine molecular testing

Area of Science:

• Genomic Medicine
• Molecular Diagnostics
• Clinical Genomics

Background:

• Gene and gene expression profiling, exemplified by the Oncotype DX® test, highlights the growing importance of molecular diagnostics in disease management.
• Advances in real-time PCR, microarray platforms, and next-generation sequencing are driving the potential of these technologies.
• Despite technological progress, the integration of novel molecular tests into routine clinical care faces significant hurdles.

Approach:

• This review aims to educate stakeholders on the current landscape of molecular diagnostics.
• It seeks to stimulate discussion regarding the challenges and opportunities in this field.
• The review advocates for collaborative efforts to build consensus, share resources, and establish standards.

Key Points:

• Clinical validity must be established in large patient populations.
• Mechanisms for incorporating molecular tests into standard clinical care need development.
• Regulated clinical laboratories must adapt to the rapid pace of technological change.

Conclusions:

• Realizing the full potential of genomic technologies for patient care requires addressing practical adoption challenges.
• Standardization, resource sharing, and consensus-building are essential for widespread implementation.
• Continued advancements in molecular diagnostics promise to revolutionize future disease management.